Motif ID: Ppara
Z-value: 2.693
Transcription factors associated with Ppara:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Ppara | ENSMUSG00000022383.7 | Ppara |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 8.3 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
2.2 | 6.6 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylserine scrambling(GO:0061589) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
2.0 | 5.9 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
1.8 | 5.5 | GO:0009644 | response to high light intensity(GO:0009644) |
1.8 | 7.1 | GO:0055095 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
1.7 | 5.2 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
1.4 | 5.8 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
1.4 | 4.3 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
1.3 | 10.5 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
1.3 | 2.5 | GO:1902995 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
1.2 | 6.2 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
1.2 | 3.6 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.2 | 18.0 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
1.1 | 9.5 | GO:0036371 | protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
1.0 | 3.1 | GO:0072554 | arterial endothelial cell fate commitment(GO:0060844) blood vessel endothelial cell fate commitment(GO:0060846) endothelial cell fate specification(GO:0060847) Notch signaling pathway involved in arterial endothelial cell fate commitment(GO:0060853) blood vessel lumenization(GO:0072554) blood vessel endothelial cell fate specification(GO:0097101) regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901295) positive regulation of heart induction(GO:1901321) regulation of canonical Wnt signaling pathway involved in heart development(GO:1905066) |
1.0 | 5.1 | GO:0071476 | cellular hypotonic response(GO:0071476) |
0.9 | 4.7 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) negative regulation of filopodium assembly(GO:0051490) |
0.9 | 5.6 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.9 | 2.8 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.9 | 2.8 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.9 | 3.6 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.9 | 5.4 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
0.9 | 2.7 | GO:0010616 | regulation of cardiac muscle adaptation(GO:0010612) negative regulation of cardiac muscle adaptation(GO:0010616) |
0.9 | 3.5 | GO:1901204 | positive regulation of guanylate cyclase activity(GO:0031284) regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) |
0.8 | 3.3 | GO:0032278 | positive regulation of gonadotropin secretion(GO:0032278) |
0.8 | 2.3 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.8 | 3.1 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.8 | 3.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 4.9 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.7 | 2.1 | GO:1900149 | positive regulation of Schwann cell migration(GO:1900149) |
0.7 | 5.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.7 | 4.0 | GO:0015879 | carnitine transport(GO:0015879) |
0.7 | 3.3 | GO:0032485 | regulation of Ral protein signal transduction(GO:0032485) |
0.7 | 2.0 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
0.6 | 1.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.6 | 4.1 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.6 | 1.7 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.6 | 2.8 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 6.0 | GO:0060539 | diaphragm development(GO:0060539) |
0.5 | 1.6 | GO:1904049 | regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.5 | 4.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.5 | 1.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.5 | 1.0 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.5 | 2.6 | GO:0090234 | cellular response to testosterone stimulus(GO:0071394) regulation of kinetochore assembly(GO:0090234) |
0.5 | 1.5 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
0.5 | 2.0 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.5 | 1.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.5 | 4.3 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.5 | 0.9 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.4 | 1.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.4 | 0.4 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.4 | 2.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 4.3 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.4 | 0.4 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.4 | 10.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 | 1.6 | GO:0055071 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.4 | 1.2 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
0.4 | 2.8 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.4 | 1.2 | GO:0048686 | regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
0.4 | 2.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.4 | 1.5 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
0.4 | 2.6 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.4 | 2.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 2.2 | GO:1901524 | regulation of autophagosome maturation(GO:1901096) regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
0.4 | 2.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.4 | 1.1 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.4 | 5.0 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.4 | 1.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.4 | 1.1 | GO:0048352 | neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) |
0.3 | 2.1 | GO:1902861 | copper ion import into cell(GO:1902861) |
0.3 | 0.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.3 | 1.7 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 1.0 | GO:0002014 | vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
0.3 | 2.0 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.3 | 1.0 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
0.3 | 5.0 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.3 | 1.0 | GO:0032493 | response to bacterial lipoprotein(GO:0032493) |
0.3 | 2.6 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.3 | 1.6 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.3 | 3.5 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.3 | 1.0 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.3 | 1.6 | GO:0030242 | pexophagy(GO:0030242) |
0.3 | 0.9 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.3 | 1.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 0.9 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
0.3 | 3.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.3 | 3.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 0.9 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.3 | 0.9 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.3 | 2.6 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
0.3 | 2.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.3 | 2.3 | GO:0031642 | negative regulation of myelination(GO:0031642) negative regulation of axon regeneration(GO:0048681) |
0.3 | 2.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.3 | 2.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 0.8 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.3 | 1.1 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.3 | 1.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.3 | 0.8 | GO:0034334 | adherens junction maintenance(GO:0034334) |
0.3 | 0.8 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.3 | 1.3 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.3 | 4.9 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.3 | 0.8 | GO:0019405 | alditol catabolic process(GO:0019405) glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.3 | 2.0 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.2 | 0.7 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.2 | 1.5 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.2 | 2.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.2 | 1.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.2 | 1.7 | GO:0051004 | plasma membrane to endosome transport(GO:0048227) regulation of lipoprotein lipase activity(GO:0051004) |
0.2 | 1.9 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 | 3.7 | GO:0034390 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.2 | 1.4 | GO:0018377 | N-terminal protein myristoylation(GO:0006499) protein myristoylation(GO:0018377) |
0.2 | 0.7 | GO:0070844 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.2 | 0.7 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 4.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 9.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.8 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 2.4 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 1.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.2 | 1.1 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.2 | 0.8 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.2 | 4.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.2 | 1.5 | GO:0048069 | eye pigmentation(GO:0048069) |
0.2 | 3.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.2 | 1.2 | GO:1903753 | cortical microtubule organization(GO:0043622) establishment of centrosome localization(GO:0051660) hard palate development(GO:0060022) negative regulation of p38MAPK cascade(GO:1903753) |
0.2 | 5.6 | GO:0097320 | membrane tubulation(GO:0097320) |
0.2 | 0.8 | GO:0006547 | histidine metabolic process(GO:0006547) |
0.2 | 2.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.2 | 1.4 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.2 | 4.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 1.0 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.2 | 1.1 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.8 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.2 | 2.6 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.2 | 2.6 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.2 | 1.5 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
0.2 | 1.1 | GO:1903056 | regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
0.2 | 1.6 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
0.2 | 0.5 | GO:0061198 | fungiform papilla formation(GO:0061198) positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
0.2 | 4.3 | GO:0030431 | sleep(GO:0030431) |
0.2 | 1.4 | GO:0060736 | prostate gland growth(GO:0060736) |
0.2 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 3.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 1.9 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.2 | 1.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 1.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.2 | 1.5 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.2 | 0.3 | GO:0003211 | cardiac ventricle formation(GO:0003211) |
0.2 | 0.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.2 | 1.1 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.7 | GO:0044330 | pyruvate transport(GO:0006848) canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.2 | 0.8 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 2.9 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.2 | 1.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 0.6 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
0.2 | 0.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.2 | 0.5 | GO:0070857 | negative regulation of receptor biosynthetic process(GO:0010871) regulation of bile acid biosynthetic process(GO:0070857) |
0.2 | 0.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 3.1 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.2 | 2.0 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.4 | GO:2000983 | regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
0.1 | 0.9 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.4 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.1 | 2.6 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 2.3 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.1 | 0.7 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.1 | 1.4 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
0.1 | 0.4 | GO:1902915 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 1.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 7.4 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 1.4 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.1 | 5.2 | GO:0007528 | neuromuscular junction development(GO:0007528) |
0.1 | 0.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.3 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 0.3 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.3 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.1 | 6.4 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 1.0 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 3.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 1.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 2.6 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.1 | 1.1 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 2.2 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 1.6 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 4.1 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.1 | 1.1 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.1 | 0.5 | GO:0015677 | copper ion import(GO:0015677) |
0.1 | 1.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 0.5 | GO:0018202 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 2.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.5 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 1.6 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.1 | 1.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.4 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
0.1 | 2.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.1 | 2.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.1 | 0.5 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.9 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.1 | 0.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.1 | 1.4 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 2.2 | GO:0097345 | mitochondrial outer membrane permeabilization(GO:0097345) |
0.1 | 0.4 | GO:0072015 | glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
0.1 | 0.5 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 3.5 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 0.5 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 2.1 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.1 | 0.1 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.1 | 1.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 1.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.2 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
0.1 | 1.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.2 | GO:0060686 | regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
0.1 | 0.9 | GO:0032691 | negative regulation of interleukin-1 beta production(GO:0032691) |
0.1 | 0.6 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 7.0 | GO:0050807 | regulation of synapse organization(GO:0050807) |
0.1 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.1 | 0.2 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.6 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.6 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.7 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 1.3 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 2.9 | GO:0014003 | oligodendrocyte development(GO:0014003) |
0.1 | 1.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 8.3 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.1 | 0.3 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.1 | 0.8 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 1.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 1.0 | GO:0001964 | startle response(GO:0001964) |
0.1 | 0.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.1 | 1.4 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.8 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.8 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.1 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
0.1 | 0.3 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.1 | 1.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 0.8 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.1 | 0.2 | GO:0015793 | glycerol transport(GO:0015793) renal water absorption(GO:0070295) |
0.1 | 0.2 | GO:2000612 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072304) negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:0072305) mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) apoptotic process involved in metanephric collecting duct development(GO:1900204) apoptotic process involved in metanephric nephron tubule development(GO:1900205) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) regulation of apoptotic process involved in metanephric collecting duct development(GO:1900214) negative regulation of apoptotic process involved in metanephric collecting duct development(GO:1900215) regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900217) negative regulation of apoptotic process involved in metanephric nephron tubule development(GO:1900218) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis(GO:1901147) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) regulation of metanephric DCT cell differentiation(GO:2000592) positive regulation of metanephric DCT cell differentiation(GO:2000594) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
0.1 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.2 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.1 | 3.9 | GO:0051101 | regulation of DNA binding(GO:0051101) |
0.1 | 1.4 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.1 | 11.1 | GO:0043413 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.1 | 0.4 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.1 | 0.5 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 | 0.3 | GO:0000022 | mitotic spindle elongation(GO:0000022) spindle midzone assembly(GO:0051255) mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.0 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.0 | 0.2 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 1.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.0 | 1.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.1 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
0.0 | 0.8 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.8 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.0 | 1.1 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.0 | 0.5 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.4 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.0 | 0.7 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.0 | 1.3 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.7 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.0 | 0.3 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.4 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.7 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.3 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.2 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 0.7 | GO:0015813 | L-glutamate transport(GO:0015813) |
0.0 | 0.3 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.0 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.0 | 0.6 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.1 | GO:0046210 | growth plate cartilage chondrocyte proliferation(GO:0003419) regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.0 | 0.4 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.9 | GO:1902850 | mitotic spindle assembly(GO:0090307) microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
0.0 | 1.5 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:0060768 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.0 | 0.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 1.0 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.0 | 0.6 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) peptidyl-threonine modification(GO:0018210) |
0.0 | 0.7 | GO:0007569 | cell aging(GO:0007569) |
0.0 | 0.6 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.7 | GO:0051017 | actin filament bundle assembly(GO:0051017) |
0.0 | 0.3 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.3 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 1.0 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
0.0 | 1.8 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.0 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.4 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.0 | 0.3 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.0 | 0.9 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.2 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.0 | 0.6 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.0 | GO:1903750 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.0 | 0.2 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
0.0 | 0.2 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.0 | 1.6 | GO:0031032 | actomyosin structure organization(GO:0031032) |
0.0 | 1.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.8 | GO:0021549 | cerebellum development(GO:0021549) |
0.0 | 0.0 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.0 | 0.0 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.0 | 0.0 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.0 | 0.3 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.0 | 0.8 | GO:0007286 | spermatid development(GO:0007286) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.8 | GO:0032280 | symmetric synapse(GO:0032280) |
1.1 | 3.3 | GO:0072534 | perineuronal net(GO:0072534) |
1.0 | 5.9 | GO:0097427 | microtubule bundle(GO:0097427) |
0.9 | 3.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.8 | 4.2 | GO:0032426 | stereocilium tip(GO:0032426) |
0.7 | 4.8 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.7 | 2.0 | GO:0032437 | cuticular plate(GO:0032437) |
0.6 | 1.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.6 | 3.1 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.5 | 5.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 8.1 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.4 | 2.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.4 | 2.0 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.4 | 5.2 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.4 | 1.2 | GO:0018444 | translation release factor complex(GO:0018444) |
0.4 | 1.5 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.3 | 2.8 | GO:0044327 | dendritic spine head(GO:0044327) |
0.3 | 3.5 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 0.9 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 1.6 | GO:0070826 | paraferritin complex(GO:0070826) |
0.3 | 0.9 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.3 | 0.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.3 | 5.4 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.3 | 2.3 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 2.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.3 | 1.1 | GO:0005745 | m-AAA complex(GO:0005745) |
0.3 | 9.9 | GO:0043034 | costamere(GO:0043034) |
0.3 | 3.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 2.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.3 | 0.8 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 1.2 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.2 | 3.6 | GO:0031528 | microvillus membrane(GO:0031528) |
0.2 | 2.4 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 2.1 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 2.3 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 6.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.2 | 1.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
0.2 | 1.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 1.0 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 10.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 1.0 | GO:0034715 | U7 snRNP(GO:0005683) pICln-Sm protein complex(GO:0034715) |
0.2 | 4.7 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.2 | 4.9 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.2 | 4.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.2 | 2.6 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.2 | 2.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.2 | 2.7 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 0.5 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
0.2 | 3.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.7 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 10.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 2.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 16.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 1.8 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 2.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 32.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 1.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 4.5 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.1 | 2.4 | GO:0071565 | nBAF complex(GO:0071565) |
0.1 | 0.8 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.6 | GO:0030131 | AP-type membrane coat adaptor complex(GO:0030119) clathrin adaptor complex(GO:0030131) |
0.1 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 1.0 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 8.0 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 1.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.1 | 3.6 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 1.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 4.2 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 2.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.1 | 1.4 | GO:0098687 | chromosomal region(GO:0098687) |
0.1 | 0.8 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.1 | 0.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.1 | 2.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.7 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 2.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 2.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 8.2 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 4.9 | GO:0005604 | basement membrane(GO:0005604) |
0.1 | 0.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.3 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.1 | 4.5 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 2.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 3.8 | GO:0016605 | PML body(GO:0016605) |
0.0 | 1.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.3 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 2.0 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.0 | 1.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 1.8 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 1.1 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 1.3 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.3 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.8 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 1.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 2.1 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 3.0 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 1.0 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 1.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 1.4 | GO:0043679 | axon terminus(GO:0043679) |
0.0 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.7 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 10.5 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 1.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 1.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.7 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.2 | GO:0042629 | mast cell granule(GO:0042629) |
0.0 | 1.3 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 2.1 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.0 | 1.0 | GO:0043209 | myelin sheath(GO:0043209) |
0.0 | 0.2 | GO:0034706 | voltage-gated sodium channel complex(GO:0001518) sodium channel complex(GO:0034706) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.0 | 0.6 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 1.2 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.2 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.0 | 0.4 | GO:0034399 | nuclear periphery(GO:0034399) |
0.0 | 1.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.5 | GO:0016234 | inclusion body(GO:0016234) |
0.0 | 0.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.2 | GO:0019908 | nuclear cyclin-dependent protein kinase holoenzyme complex(GO:0019908) |
0.0 | 0.2 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 1.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.0 | 0.9 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 2.2 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 1.4 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 1.5 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 0.1 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.8 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
1.7 | 10.0 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
1.4 | 7.1 | GO:0055100 | adiponectin binding(GO:0055100) |
1.3 | 5.3 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
1.3 | 4.0 | GO:0005124 | scavenger receptor binding(GO:0005124) |
1.3 | 3.9 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.2 | 7.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.2 | 3.6 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) oncostatin-M receptor activity(GO:0004924) |
1.2 | 4.7 | GO:0070976 | calcium-independent protein kinase C activity(GO:0004699) TIR domain binding(GO:0070976) |
1.2 | 3.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.9 | 2.8 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.8 | 2.5 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) |
0.8 | 2.5 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.8 | 4.8 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
0.8 | 11.0 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.7 | 3.7 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.7 | 0.7 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
0.7 | 2.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.7 | 2.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.6 | 3.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.6 | 2.4 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.6 | 6.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.6 | 2.3 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 2.9 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.5 | 9.2 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.5 | 3.7 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.5 | 1.5 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.5 | 1.4 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.5 | 1.4 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.5 | 3.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 1.4 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.5 | 4.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.3 | GO:0048045 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
0.4 | 8.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.4 | 2.6 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.4 | 1.6 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.4 | 2.0 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.4 | 5.4 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.4 | 1.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.4 | 6.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.4 | 1.1 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.3 | 1.4 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 1.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.3 | 1.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 1.6 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.3 | 1.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 2.8 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 1.6 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.3 | 2.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 0.9 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) bisphosphoglycerate 2-phosphatase activity(GO:0004083) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 0.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.3 | 1.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.3 | 5.7 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 1.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.3 | 2.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.3 | 1.1 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.3 | 8.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 0.8 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.3 | 2.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.3 | 7.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.3 | 0.8 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.3 | 3.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.3 | 1.0 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 1.0 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.2 | 0.7 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.2 | 1.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.2 | 2.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 0.9 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) |
0.2 | 4.5 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 1.4 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.2 | 2.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.2 | 1.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
0.2 | 3.2 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.2 | 0.9 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.2 | 0.9 | GO:0043515 | kinetochore binding(GO:0043515) |
0.2 | 1.8 | GO:0008318 | protein prenyltransferase activity(GO:0008318) |
0.2 | 2.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.2 | 2.6 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.2 | 2.6 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 1.5 | GO:0032795 | G-protein coupled adenosine receptor activity(GO:0001609) heterotrimeric G-protein binding(GO:0032795) |
0.2 | 2.1 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.2 | 20.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.2 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 1.0 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.2 | 4.6 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 1.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.2 | 1.0 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 2.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 1.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.2 | 7.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 1.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 1.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.7 | GO:0008488 | gamma-glutamyl carboxylase activity(GO:0008488) |
0.2 | 0.5 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.2 | 1.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.2 | 0.7 | GO:0050436 | microfibril binding(GO:0050436) |
0.2 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.2 | 1.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 5.6 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.2 | 1.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 1.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 4.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.1 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 4.7 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 1.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.1 | 0.6 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 3.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.1 | 1.2 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 2.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 1.4 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.1 | 0.4 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 3.4 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.3 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.1 | 0.9 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.1 | 1.4 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 4.1 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.7 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.1 | 2.3 | GO:0035380 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) mevaldate reductase activity(GO:0004495) gluconate dehydrogenase activity(GO:0008875) epoxide dehydrogenase activity(GO:0018451) 5-exo-hydroxycamphor dehydrogenase activity(GO:0018452) 2-hydroxytetrahydrofuran dehydrogenase activity(GO:0018453) acetoin dehydrogenase activity(GO:0019152) phenylcoumaran benzylic ether reductase activity(GO:0032442) D-xylose:NADP reductase activity(GO:0032866) L-arabinose:NADP reductase activity(GO:0032867) D-arabinitol dehydrogenase, D-ribulose forming (NADP+) activity(GO:0033709) (R)-(-)-1,2,3,4-tetrahydronaphthol dehydrogenase activity(GO:0034831) 3-hydroxymenthone dehydrogenase activity(GO:0034840) very long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0035380) dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) (R)-2-hydroxyisocaproate dehydrogenase activity(GO:0043713) L-arabinose 1-dehydrogenase (NADP+) activity(GO:0044103) L-xylulose reductase (NAD+) activity(GO:0044105) 3-ketoglucose-reductase activity(GO:0048258) D-arabinitol dehydrogenase, D-xylulose forming (NADP+) activity(GO:0052677) |
0.1 | 2.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.1 | 0.7 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.1 | 0.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 1.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 1.1 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
0.1 | 1.7 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.1 | 2.7 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 0.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.1 | 1.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 1.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.1 | 3.2 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 0.9 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 5.7 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 9.5 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 3.5 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 1.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 2.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 2.8 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 3.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 1.9 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 1.0 | GO:0017016 | Ras GTPase binding(GO:0017016) |
0.1 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 1.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.8 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.1 | 0.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.5 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 1.2 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.1 | 4.5 | GO:0002039 | p53 binding(GO:0002039) |
0.1 | 2.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 1.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.7 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.1 | 2.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.9 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.1 | 0.4 | GO:0048185 | activin binding(GO:0048185) |
0.1 | 1.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.3 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.1 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 2.0 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 1.0 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 1.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.4 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) insulin-like growth factor II binding(GO:0031995) |
0.0 | 0.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.9 | GO:0005313 | L-glutamate transmembrane transporter activity(GO:0005313) |
0.0 | 0.9 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 3.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 2.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 1.1 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 1.2 | GO:0004120 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
0.0 | 1.3 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 0.2 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.4 | GO:0030553 | cGMP binding(GO:0030553) 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.0 | 0.5 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 2.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.1 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.0 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.1 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 0.5 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 1.4 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 1.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.9 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 2.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 1.5 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.7 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.7 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 4.0 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 8.5 | GO:0016879 | ligase activity, forming carbon-nitrogen bonds(GO:0016879) |
0.0 | 0.5 | GO:0050253 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) retinyl-palmitate esterase activity(GO:0050253) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
0.0 | 0.5 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 1.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.1 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.0 | 0.3 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.7 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 1.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.5 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.6 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 0.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 3.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.6 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.0 | 3.5 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.5 | GO:0034930 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) heparan sulfate 2-O-sulfotransferase activity(GO:0004394) HNK-1 sulfotransferase activity(GO:0016232) heparan sulfate 6-O-sulfotransferase activity(GO:0017095) trans-9R,10R-dihydrodiolphenanthrene sulfotransferase activity(GO:0018721) 1-phenanthrol sulfotransferase activity(GO:0018722) 3-phenanthrol sulfotransferase activity(GO:0018723) 4-phenanthrol sulfotransferase activity(GO:0018724) trans-3,4-dihydrodiolphenanthrene sulfotransferase activity(GO:0018725) 9-phenanthrol sulfotransferase activity(GO:0018726) 2-phenanthrol sulfotransferase activity(GO:0018727) phenanthrol sulfotransferase activity(GO:0019111) 1-hydroxypyrene sulfotransferase activity(GO:0034930) proteoglycan sulfotransferase activity(GO:0050698) cholesterol sulfotransferase activity(GO:0051922) hydroxyjasmonate sulfotransferase activity(GO:0080131) |
0.0 | 1.6 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.9 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.3 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 1.5 | GO:0000989 | transcription factor activity, transcription factor binding(GO:0000989) |
0.0 | 0.0 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.2 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.0 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.3 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 1.3 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.0 | 0.2 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |